{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:44:20Z","timestamp":1785915860295,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD01905200"],"award-info":[{"award-number":["2025ZD01905200"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jiph.2026.103284","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:10:25Z","timestamp":1781208625000},"page":"103284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prioritizing tuberculosis preventive therapy for IGRA-negative people living with HIV initiating antiretroviral therapy"],"prefix":"10.1016","volume":"19","author":[{"given":"Wenjun","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangkai","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9052-256X","authenticated-orcid":false,"given":"Shuibao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2026.103284_bib1","series-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.jiph.2026.103284_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2025.102607","article-title":"HIV co-infection is associated with increased HLA-DR expression by Mycobacterium tuberculosis-specific CD4 T cells in people with latent tuberculosis infection","volume":"151","author":"Khayumbi","year":"2025","journal-title":"Tuberc (Edinb)"},{"issue":"RR-4","key":"10.1016\/j.jiph.2026.103284_bib3","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"10.1016\/j.jiph.2026.103284_bib4","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1086\/424851","article-title":"Does tuberculosis increase HIV load?","volume":"190","author":"Day","year":"2004","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.jiph.2026.103284_bib5","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/QAD.0b013e32830e010c","article-title":"Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence","volume":"22","author":"L\u00f3pez-Gatell","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2026.103284_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.107876","article-title":"Tuberculosis and HIV coinfection: progress and challenges towards reducing incidence and mortality","volume":"155","author":"Sossen","year":"2025","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2026.103284_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/011570162X349937250206073759","article-title":"Latent tuberculosis screening and active tuberculosis disease development in people living with HIV: a multicenter retrospective cohort study in Turkiye","volume":"23","author":"Kuscu","year":"2025","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.jiph.2026.103284_bib8","series-title":"Bethesda (MD)","author":"Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV [Internet]","year":"2025"},{"issue":"30","key":"10.1016\/j.jiph.2026.103284_bib9","first-page":"3796","article-title":"Influencing factors of latent tuberculosis infection in patients living with HIV\/AIDS","volume":"25","author":"Jiang","year":"2022","journal-title":"Chin Gen Pract"},{"issue":"1","key":"10.1016\/j.jiph.2026.103284_bib10","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2352-3018(20)30299-X","article-title":"Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data","volume":"8","author":"Ross","year":"2021","journal-title":"Lancet HIV"},{"issue":"7","key":"10.1016\/j.jiph.2026.103284_bib11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/597351","article-title":"Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals","volume":"48","author":"Aichelburg","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2026.103284_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1155\/2009\/658382","article-title":"Tuberculosis screening and active tuberculosis among HIV-infected persons in a Canadian tertiary care centre","volume":"20","author":"Brassard","year":"2009","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2026.103284_bib13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1186\/s12889-016-3539-2","article-title":"Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in The Netherlands: a mixed-method design","volume":"16","author":"Evenblij","year":"2016","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1016\/j.jiph.2026.103284_bib14","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1086\/516608","article-title":"Reducing tuberculosis incidence in HIV-infected patients by tuberculin skin testing, preventive treatment, and antiretroviral therapy","volume":"44","author":"Hamlyn","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2026.103284_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cmi.2021.07.036","article-title":"Tuberculosis incidence and mortality in people living with human immunodeficiency virus: a Danish nationwide cohort study","volume":"28","author":"Martin-Iguacel","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"11-12","key":"10.1016\/j.jiph.2026.103284_bib16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/23744235.2018.1486511","article-title":"Incidence of tuberculosis and the need of prophylactic treatment in persons living with HIV in Stockholm during the era of anti-retroviral therapy 1996-2013","volume":"50","author":"Norrby","year":"2018","journal-title":"Infect Dis (Lond)"},{"issue":"10","key":"10.1016\/j.jiph.2026.103284_bib17","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jiph.2026.103284_bib18","doi-asserted-by":"crossref","DOI":"10.2196\/36242","article-title":"Unbalanced risk of pulmonary tuberculosis in China at the subnational scale: spatiotemporal analysis","volume":"8","author":"Hu","year":"2022","journal-title":"JMIR Public Health Surveill"},{"issue":"RR-17","key":"10.1016\/j.jiph.2026.103284_bib19","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","author":"Castro","year":"1992","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.jiph.2026.103284_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/QAD.0000000000003747","article-title":"Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings","volume":"38","author":"van Geuns","year":"2024","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.jiph.2026.103284_bib21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"Danel","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jiph.2026.103284_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/resp.14184","article-title":"The challenge of minimizing tuberculosis burden in people living with HIV in the Asia Pacific","volume":"27","author":"Lee","year":"2022","journal-title":"Respirology"},{"issue":"40","key":"10.1016\/j.jiph.2026.103284_bib23","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2019.34.e259","article-title":"Good agreement between an interferon gamma release assay and tuberculin skin tests in testing for latent tuberculosis infection among HIV-infected patients in Indonesia","volume":"34","author":"Reviono","year":"2019","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.jiph.2026.103284_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jiph.2026.103284_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiph.2026.103284_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1471-2334-12-169","article-title":"Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test","volume":"12","author":"Ramos","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.jiph.2026.103284_bib27","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.jiph.2026.103284_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034156","article-title":"Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community","volume":"7","author":"Gupta","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jiph.2026.103284_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s12879-023-08533-0","article-title":"The incidence rate of tuberculosis and its associated factors among HIV-positive persons in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"23","author":"Wondmeneh","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.jiph.2026.103284_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01904-2024","article-title":"Incident tuberculosis in people with HIV across Europe from 2012 to 2022: incidence rates, risk factors and regional differences in a multicentre cohort study","volume":"65","author":"Kraef","year":"2025","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.jiph.2026.103284_bib31","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/S2352-3018(15)00063-6","article-title":"Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland","volume":"2","author":"Gupta","year":"2015","journal-title":"Lancet HIV"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126001565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126001565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:46:43Z","timestamp":1785912403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034126001565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1876034126001565"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103284","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prioritizing tuberculosis preventive therapy for IGRA-negative people living with HIV initiating antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103284"}}